Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin can learn their options by contacting the DrugNews Center or speaking with a lawyer.
New York, NY (PRWEB) October 18, 2013
The drug safety advocates at DrugNews.net are alerting patients who have taken the birth control drugs Yaz or Yasmin of updated legal news regarding claims that the drugs caused blood clot injuries. Court records released this week indicate the number of claims has risen slightly in the past month*.
The DrugNews Center is a free resource for patients who take popular prescription drugs, offering one place to find the latest research, safety alerts, recalls and legal news. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.
The birth control safety center at DrugNews has added warnings from drug experts like the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots.
A significant number of women have already filed a Yaz lawsuit alleging side effects, leading to the consolidation of cases to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
Now, DrugNews has learned the latest court records from the Judicial Panel on Multidistrict Litigation reveal the amount of pending Yaz lawsuits has actually risen slightly from 9,838 on September 11 to 9,873 on October 17*.
The resource center has also discovered that the maker of Yaz and Yasmin, Bayer, has spent more than $1.4 billion so far to settle around 6,750 patient claims alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)****.
Lawyers are still available to help those who believe they have been injured. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin can learn their options by contacting the DrugNews Center or speaking with a lawyer.
Due to the complexity of federal MDL cases, patients should seek a lawyer with experience in defective drug litigation. DrugNews only recommends lawyers who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*JPML, 10/17/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer Stockholder’s Newsletter Q2, Explanatory Notes, Legal Risks, 7/31/13; stockholders-newsletter-q2-2013.bayer.com/en/explanatory-notes.aspx